Stocktoria
Connect Biopharma Holdings Ltd CNTB
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-03-19
Connect Biopharma Holdings Ltd statistics & valuation
Market cap$137.9M
P / B3.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating margin | -90740.6% | -86.2% | — |
| Net margin | -86687.5% | -60.0% | — |
| FCF margin | -80687.5% | -93.6% | — |
| Return on assets | -98.9% | -15.4% | -48.8% |
| Return on equity | -132.2% | -17.0% | -61.2% |
| Current ratio | 3.74 | 11.46 | 4.85 |
| Revenue growth | -99.8% | — | — |
Source: SEC EDGAR filings · CIK 0001835268 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.